Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database
Open Access
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for managementInternational Journal of Women's Dermatology, 2021
- Stevens-Johnson syndrome/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance databaseeClinicalMedicine, 2021
- A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint InhibitorsJournal of Medical Toxicology, 2021
- Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitorsCancer Immunology, Immunotherapy, 2021
- Cutaneous immune-related adverse events to checkpoint inhibitorsClinics in Dermatology, 2020
- Skin Reactions to Immune Checkpoint Inhibitors2018
- Dermatologic Reactions to Immune Checkpoint InhibitorsAmerican Journal of Clinical Dermatology, 2017
- Cutaneous adverse effects of the immune checkpoint inhibitorsCurrent Problems in Cancer, 2017
- Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptorEuropean Journal of Cancer, 2016
- The reporting odds ratio and its advantages over the proportional reporting ratioPharmacoepidemiology and Drug Safety, 2004